Related Experiment Videos

Perforated peptic ulcer disease in children: association of corticosteroid therapy

S W Bickler1, M W Harrison, J R Campbell

  • 1Department of Surgery, School of Medicine, Oregon Health Sciences University, Portland 97201.

Insights

Corticosteroid use in children with severe underlying diseases is linked to perforated peptic ulcers. Prophylaxis is recommended for these children to prevent serious gastrointestinal complications.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Outcomes
  • Pharmacovigilance

Background:

  • Perforated peptic ulcer disease (PUD) is a rare but serious condition in children.
  • Children with severe underlying diseases are at increased risk.
  • Corticosteroids are frequently used in managing chronic pediatric illnesses.

Observation:

  • Four pediatric cases of perforated PUD were identified over 15 years.
  • All patients had severe comorbidities and were on corticosteroid therapy.
  • Presenting symptoms included signs of a perforated viscus with pneumoperitoneum.

Findings:

  • Simple closure and omental patching of the perforated ulcer led to successful outcomes with no mortality or morbidity.
  • No recurrence of ulcers was observed post-operatively.
  • Literature review indicated corticosteroids were associated with 17.8% of pediatric perforated PUD cases.

Implications:

  • Corticosteroid therapy may contribute to the risk of PUD in vulnerable pediatric populations.
  • Prophylactic measures against PUD should be considered for all children receiving corticosteroids.
  • Effective surgical management (simple closure and omental patching) offers favorable outcomes for perforated PUD in children.

Related Concept Videos